TABLE OF CONTENTS
Volume 14, Issue 20 (October 2007)
Review
Progress and Prospects: Gene Therapy Clinical Trials (Part 1)
Eric Alton
Gene Ther 14: 1439-1447; doi:10.1038/sj.gt.3303001
Original Articles
Direct selection of targeted adenovirus vectors by random peptide display on the fiber knob
Y Miura, K Yoshida, T Nishimoto, K Hatanaka, S Ohnami, M Asaka, J T Douglas, D T Curiel, T Yoshida and K Aoki
Gene Ther 14: 1448-1460; advance online publication, August 16, 2007; doi:10.1038/sj.gt.3303007
Gene delivery by the hSP-B promoter to lung alveolar type II epithelial cells in LAL-knockout mice through bone marrow mesenchymal stem cells
C Yan, X Lian, Y Dai, X Wang, P Qu, A White, Y Qin and H Du
Gene Ther 14: 1461-1470; advance online publication, August 16, 2007; doi:10.1038/sj.gt.3303006
GCV modulates the antitumoural efficacy of a replicative adenovirus expressing the TAT8-TK as a late gene in a pancreatic tumour model
A Cascante, D Abate-Daga, L Garcia-Rodríguez, J R González, R Alemany and C Fillat
Gene Ther 14: 1471-1480; advance online publication, August 23, 2007; doi:10.1038/sj.gt.3303008
In vivo splenic CD11c cells downregulate CD4 T-cell response thereby decreasing systemic immunity to gene-modified tumour cell vaccine
S Cayeux, B Bukarica, C Buschow, J Charo, M Bunse, B Dörken and T Blankenstein
Gene Ther 14: 1481-1491; advance online publication, August 16, 2007; doi:10.1038/sj.gt.3303003
Expression of CFTR from a ciliated cell-specific promoter is ineffective at correcting nasal potential difference in CF mice
L E Ostrowski, W Yin, P S Diggs, T D Rogers, W K O'Neal and B R Grubb
Gene Ther 14: 1492-1501; advance online publication, July 19, 2007; doi:10.1038/sj.gt.3302994
